Literature DB >> 11483856

Analysis of candidate antagonists of IAP-mediated caspase inhibition using yeast reconstituted with the mammalian Apaf-1-activated apoptosis mechanism.

C J Hawkins1, J Silke, A M Verhagen, R Foster, P G Ekert, D M Ashley.   

Abstract

We have reconstituted the Apaf-1-activated apoptosis mechanism in Sacchromyces cerevisiae such that the presence of a constitutively active form of Apaf-1 together with both Caspase-9 and Caspase-3 results in yeast death. This system is a good model of the Apaf-1-activated pathway in mammalian cells: MIHA (XIAP/hILP), and to a lesser degree MIHB (c-IAP1/HIAP2) and MIHC (c-IAP-2/HIAP1) can inhibit caspases in this system, and protection by IAPs (inhibitor of apoptosis) can be abrogated by coexpression of the Drosophila pro-apoptotic proteins HID and GRIM or the mammalian protein DIABLO/Smac. Using this system we demonstrate that unlike DIABLO/Smac, other proteins which interact with mammalian IAPs (TAB-1, Zap-1, Traf-1 and Traf-2) do not act to antagonise IAP- mediated caspase inhibition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483856     DOI: 10.1023/a:1011329917895

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  12 in total

1.  Mature DIABLO/Smac is produced by the IMP protease complex on the mitochondrial inner membrane.

Authors:  Lena Burri; Yvan Strahm; Christine J Hawkins; Ian E Gentle; Michelle A Puryer; Anne Verhagen; Bernard Callus; David Vaux; Trevor Lithgow
Journal:  Mol Biol Cell       Date:  2005-04-06       Impact factor: 4.138

2.  Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP.

Authors:  J Silke; P G Ekert; C L Day; C J Hawkins; M Baca; J Chew; M Pakusch; A M Verhagen; D L Vaux
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

3.  The N Terminus of the Vaccinia Virus Protein F1L Is an Intrinsically Unstructured Region That Is Not Involved in Apoptosis Regulation.

Authors:  Sofia Caria; Bevan Marshall; Robyn-Lee Burton; Stephanie Campbell; Delara Pantaki-Eimany; Christine J Hawkins; Michele Barry; Marc Kvansakul
Journal:  J Biol Chem       Date:  2016-05-05       Impact factor: 5.157

4.  Vaccinia Virus Encodes a Novel Inhibitor of Apoptosis That Associates with the Apoptosome.

Authors:  Melissa R Ryerson; Monique M Richards; Marc Kvansakul; Christine J Hawkins; Joanna L Shisler
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 5.  Contribution of yeast models to virus research.

Authors:  R Sahaya Glingston; Jyoti Yadav; Jitika Rajpoot; Neha Joshi; Shirisha Nagotu
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-04       Impact factor: 4.813

6.  Functional and biochemical characterization of the baculovirus caspase inhibitor MaviP35.

Authors:  I L Brand; M M Green; S Civciristov; D Pantaki-Eimany; C George; T R Gort; N Huang; R J Clem; C J Hawkins
Journal:  Cell Death Dis       Date:  2011-12-15       Impact factor: 8.469

7.  Analysis of the minimal specificity of caspase-2 and identification of Ac-VDTTD-AFC as a caspase-2-selective peptide substrate.

Authors:  Tanja Kitevska; Sarah J Roberts; Delara Pantaki-Eimany; Sarah E Boyd; Fiona L Scott; Christine J Hawkins
Journal:  Biosci Rep       Date:  2014-04-01       Impact factor: 3.840

8.  Versatile assays for high throughput screening for activators or inhibitors of intracellular proteases and their cellular regulators.

Authors:  Hideki Hayashi; Michael Cuddy; Vincent Chih-Wen Shu; Kenneth W Yip; Charitha Madiraju; Paul Diaz; Toshifumi Matsuyama; Muneshige Kaibara; Kohtaro Taniyama; Stefan Vasile; Eduard Sergienko; John C Reed
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

9.  Yeast techniques for modeling drugs targeting Bcl-2 and caspase family members.

Authors:  T E Beaumont; T M Shekhar; L Kaur; D Pantaki-Eimany; M Kvansakul; C J Hawkins
Journal:  Cell Death Dis       Date:  2013-05-02       Impact factor: 8.469

Review 10.  Survivin as a preferential target for cancer therapy.

Authors:  Mahsa Mobahat; Aru Narendran; Karl Riabowol
Journal:  Int J Mol Sci       Date:  2014-02-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.